Neoadjuvant, non-operative regimens being investigated in rectal cancer

Investigators conducting the multi-centre phase Il/ III PROSPECT trial are comparing the FOLFOX chemotherapy regimen to the standard chemo-radiotherapy, followed by surgery and adjuvant therapy in patients with locally advanced rectal cancer to determine whether or not patients can be spared the toxicity of pelvic radiotherapy.